CCL2 and infectious otitis media: Cholestyramine-supplementation of mice prior to AOM-injection was found to reduce AOM-induced neuroinflammation by inhibiting microglia activation and reducing the expression of the proinflammatory mediators CCL2, IL-6 and TNFα in the cortex.